Ceftazim 1 gm/vial (IM/IV Injection)
Medicine Details
Category | Details |
---|---|
Generic | Ceftazidime pentahydrate |
Company | Aristopharma ltd |
Also available as |
Indications
- Lower Respiratory Tract Infections
- Skin and Skin Structure Infections
- Urinary Tract Infections
- Bacterial Septicemia
- Bone and Joint Infections
- Gynecologic Infections
- Intraabdominal Infections
- Central Nervous System Infections
Pharmacology
Ceftazidime is a semisynthetic, broad-spectrum, beta-lactam antibiotic for parenteral administration. It is bactericidal in action exerting its effect by inhibition of enzymes responsible for cell-wall synthesis.
Dosage
The usual adult dosage is 1 gram administered intravenously or intramuscularly every 8 to 12 hours. Dosage and route should be determined by the susceptibility of the causative organisms, the severity of infection, and the condition and renal function of the patient.
Administration
Ceftazidime may be given intravenously or by deep IM injection into a large muscle mass such as the upper outer quadrant of the gluteus maximus or lateral proof of the thigh.
Contraindications
Ceftazidime is contraindicated in patients who have shown hypersensitivity to Ceftazidime or the cephalosporin group of antibiotics.
Side Effects
- Local reactions following IV injection
- Allergic and gastrointestinal reactions
- Hypersensitivity reactions
- Gastrointestinal symptoms
- Central nervous system reactions
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Ceftazidime is excreted in human milk in low concentrations
Precautions & Warnings
The total daily dosage should be reduced when Ceftazim is administered to patients with renal insufficiency.
Use in Special Populations
- Impaired Renal Function
- Dosage in peritoneal dialysis
- Impaired Hepatic Function
Overdose Effects
Reactions have included seizure activity, encephalopathy, asterixis, neuromuscular excitability, and coma. Patients who receive an acute overdosage should be carefully observed and given supportive treatment.
Therapeutic Class
Third generation Cephalosporins
Reconstitution
Single-dose vial Administration Amount of WFI to be added: 250 mg IM in 1.5 ml, 250 mg IV in 5 ml, 500 mg IM in 1.5 ml, 500 mg IV in 5 ml and 1 g IM in 3 ml, 1 g IV in 10 ml.
Storage Conditions
Store below 25°C, protected from light and moisture. Reconstituted solutions are stable for up to 24 h if stored between 2°C-8°C.
Related Brands
- Cozid 1 gm/vial (IM/IV Injection) - beacon-pharmaceuticals-plc
- Cozid 250 mg/vial (IM/IV Injection) - beacon-pharmaceuticals-plc
- Lesero 500 mg/vial (IM/IV Injection) - ziska-pharmaceuticals-ltd
- Lesero 1 gm/vial (IM/IV Injection) - ziska-pharmaceuticals-ltd
- Sidobac 500 mg/vial (IM/IV Injection) - incepta-pharmaceuticals-ltd